Products to Support Applied Research Towards Zero Suicide Healthcare Systems (R43/R44 Clinical Trial Optional)

Funder: National Institutes of Health

Due Date: 4/5/2019

Budget: $1,500,000

Opportunity: PAR-18-269

This funding opportunity announcement (FOA) is intended to support Small Business Innovation Research (SBIR) grants that develop novel technologies for the purpose of advancing the National Action Alliance for Suicide Prevention’s “Zero Suicide” goal of preventing suicide events (attempts, deaths) among individuals receiving treatment within health care systems. Zero Suicide is a commitment to the prevention of suicide among individuals served by health care systems and is also a specific set of health care strategies and tools intended to eliminate suicide events.  Research is still needed, however, to implement these goals effectively, and the incorporation of health information technology (health IT) products into this care program is critical.  As such, this FOA specifically supports SBIR grants to develop technologies that enable healthcare settings to improve the development, management and/or delivery of services under the Zero Suicideframework.

Leave a Reply